Dagogo-Jack S - Search Results

1

Philip E. Cryer, MD: Seminal Contributions to the Understanding of Hypoglycemia and Glucose Counterregulation and the Discovery of HAAF (Cryer Syndrome).

Dagogo-Jack S. Dagogo-Jack S. Diabetes Care. 2015 Dec;38(12):2193-9. doi: 10.2337/dc15-0533. Diabetes Care. 2015. PMID: 26604275 Free PMC article.

2

Hypoglycemia in type 1 diabetes mellitus: pathophysiology and prevention.

Dagogo-Jack S. Dagogo-Jack S. Treat Endocrinol. 2004;3(2):91-103. doi: 10.2165/00024677-200403020-00004. Treat Endocrinol. 2004. PMID: 15743105 Review.

3

Barriers to achieving optimal glycemic control in a multi-ethnic society: a US focus.

Dagogo-Jack S, Funnell MM, Davidson J. Dagogo-Jack S, et al. Curr Diabetes Rev. 2006 Aug;2(3):285-93. doi: 10.2174/157339906777950606. Curr Diabetes Rev. 2006. PMID: 18220633 Review.

4

Predicting diabetes: our relentless quest for genomic nuggets.

Dagogo-Jack S. Dagogo-Jack S. Diabetes Care. 2012 Feb;35(2):193-5. doi: 10.2337/dc11-2106. Diabetes Care. 2012. PMID: 22275439 Free PMC article. No abstract available.

5

Hypoglycemia in patients with type 1 diabetes: epidemiology, pathogenesis, and prevention.

Awoniyi O, Rehman R, Dagogo-Jack S. Awoniyi O, et al. Curr Diab Rep. 2013 Oct;13(5):669-78. doi: 10.1007/s11892-013-0411-y. Curr Diab Rep. 2013. PMID: 23912765 Review.

6

2015 Presidential Address: 75 Years of Battling Diabetes--Our Global Challenge.

Dagogo-Jack S. Dagogo-Jack S. Diabetes Care. 2016 Jan;39(1):3-9. doi: 10.2337/dc15-1818. Diabetes Care. 2016. PMID: 26696655 Free PMC article.

7

Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease.

Inzucchi SE, Viscoli CM, Young LH, Furie KL, Gorman M, Lovejoy AM, Dagogo-Jack S, Ismail-Beigi F, Korytkowski MT, Pratley RE, Schwartz GG, Kernan WN; IRIS Trial Investigators. Inzucchi SE, et al. Diabetes Care. 2016 Oct;39(10):1684-92. doi: 10.2337/dc16-0798. Epub 2016 Jul 27. Diabetes Care. 2016. PMID: 27465265 Free PMC article. Clinical Trial.

8

Hyperglycemic, high anion-gap metabolic acidosis in patients receiving SGLT-2 inhibitors for diabetes management.

Kum-Nji JS, Gosmanov AR, Steinberg H, Dagogo-Jack S. Kum-Nji JS, et al. J Diabetes Complications. 2017 Mar;31(3):611-614. doi: 10.1016/j.jdiacomp.2016.11.004. Epub 2016 Nov 9. J Diabetes Complications. 2017. PMID: 27913012

9

Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study.

Braffett BH, Dagogo-Jack S, Bebu I, Sivitz WI, Larkin M, Kolterman O, Lachin JM; DCCT/EDIC Research Group. Braffett BH, et al. Diabetes Care. 2019 Apr;42(4):657-664. doi: 10.2337/dc18-1574. Epub 2019 Feb 6. Diabetes Care. 2019. PMID: 30728218 Free PMC article. Clinical Trial.

10

Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS).

Perreault L, Pan Q, Schroeder EB, Kalyani RR, Bray GA, Dagogo-Jack S, White NH, Goldberg RB, Kahn SE, Knowler WC, Mathioudakis N, Dabelea D; Diabetes Prevention Program Research Group. Perreault L, et al. Diabetes Care. 2019 Sep;42(9):1809-1815. doi: 10.2337/dc19-0244. Epub 2019 Jul 18. Diabetes Care. 2019. PMID: 31320445 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

304 results

Search Page